Abstract
A series of piperazinephen-1-ylehtylamines were synthesized and evaluated for their biological activity at the human melanocortin-4 receptor. This modification reduced the size and flexibility of the N-alkyl side-chain of some earlier lead compounds, while maintained the low nanomolar binding affinity.
Keywords: Melanocortin, antagonist, piperazinephenylamine, synthesis
Letters in Drug Design & Discovery
Title: Synthesis of Piperazinephen-1-ylethylamines as Potent and Selective Antagonists of the Human Melanocortin-4 Receptor
Volume: 3 Issue: 5
Author(s): Fabio C. Tucci, Joe A. Tran, Wanlong Jiang, Joseph Pontillo, Dragan Marinkovic, Nicole S. White, Melissa Arellano, Beth A. Fleck, Jenny Wen, John Saunders, Alan C. Foster and Chen Chen
Affiliation:
Keywords: Melanocortin, antagonist, piperazinephenylamine, synthesis
Abstract: A series of piperazinephen-1-ylehtylamines were synthesized and evaluated for their biological activity at the human melanocortin-4 receptor. This modification reduced the size and flexibility of the N-alkyl side-chain of some earlier lead compounds, while maintained the low nanomolar binding affinity.
Export Options
About this article
Cite this article as:
Tucci C. Fabio, Tran A. Joe, Jiang Wanlong, Pontillo Joseph, Marinkovic Dragan, White S. Nicole, Arellano Melissa, Fleck A. Beth, Wen Jenny, Saunders John, Foster C. Alan and Chen Chen, Synthesis of Piperazinephen-1-ylethylamines as Potent and Selective Antagonists of the Human Melanocortin-4 Receptor, Letters in Drug Design & Discovery 2006; 3(5) . https://dx.doi.org/10.2174/157018006777574249
DOI https://dx.doi.org/10.2174/157018006777574249 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues